日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A Time and Motion Study Comparing Subcutaneous Pembrolizumab Versus Intravenous Pembrolizumab in Combination with Chemotherapy for the Treatment of Metastatic Non-small Cell Lung Cancer

一项比较皮下注射帕博利珠单抗与静脉注射帕博利珠单抗联合化疗治疗转移性非小细胞肺癌的时间和动作研究

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-025-03365-7
De Cock, Erwin; Oskar, Sabine; Lourdudoss, Cecilia; Eiras, Renata; Pietanza, M Catherine; Arunachalam, Ashwini; Alves, Gustavo; Martinengo, Gaston Lucas; Felip, Enriqueta
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Corrigendum to "Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC [JTO Clinical and Research Reports Vol. 4 No. 1: 100431]

更正“组织肿瘤突变负荷和突变状态与帕博利珠单抗联合化疗与单纯化疗治疗转移性非小细胞肺癌的临床结果的关联”[JTO临床与研究报告 第4卷 第1期：100431]

期刊:JTO Clinical and Research Reports
影响因子:3.5
doi:10.1016/j.jtocrr.2025.100892
Garassino, Marina C; Gadgeel, Shirish; Novello, Silvia; Halmos, Balazs; Felip, Enriqueta; Speranza, Giovanna; Hui, Rina; Garon, Edward B; Horinouchi, Hidehito; Sugawara, Shunichi; Rodriguez-Abreu, Delvys; Reck, Martin; Cristescu, Razvan; Aurora-Garg, Deepti; Loboda, Andrey; Lunceford, Jared; Kobie, Julie; Ayers, Mark; Piperdi, Bilal; Pietanza, M Catherine; Paz-Ares, Luis
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, EGFR-Mutant, Metastatic Nonsquamous Non-Small Cell Lung Cancer

KEYNOTE-789 III期研究：培美曲塞联合铂类药物，加或不加帕博利珠单抗治疗酪氨酸激酶抑制剂耐药、EGFR突变、转移性非鳞状非小细胞肺癌

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.23.02747
Yang, James Chih-Hsin; Lee, Dae Ho; Lee, Jong-Seok; Fan, Yun; de Marinis, Filippo; Iwama, Eiji; Inoue, Takako; Rodríguez-Cid, Jerónimo; Zhang, Li; Yang, Cheng-Ta; de la Mora Jimenez, Emmanuel; Zhou, Jianying; Pérol, Maurice; Lee, Ki Hyeong; Vicente, David; Ichihara, Eiki; Riely, Gregory J; Luo, Yiwen; Chirovsky, Diana; Pietanza, M Catherine; Bhagwati, Niyati; Lu, Shun
肺癌
肿瘤
肿瘤免疫
信号转导
EGF
EGFR
细胞生物学
发表日期：2024
文献求助 收藏

Pembrolizumab Plus Pemetrexed and Platinum in Nonsquamous Non-Small-Cell Lung Cancer: 5-Year Outcomes From the Phase 3 KEYNOTE-189 Study

帕博利珠单抗联合培美曲塞和铂类药物治疗非鳞状非小细胞肺癌：KEYNOTE-189 III期研究的5年结果

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.22.01989
Garassino, Marina C; Gadgeel, Shirish; Speranza, Giovanna; Felip, Enriqueta; Esteban, Emilio; Dómine, Manuel; Hochmair, Maximilian J; Powell, Steven F; Bischoff, Helge G; Peled, Nir; Grossi, Francesco; Jennens, Ross R; Reck, Martin; Hui, Rina; Garon, Edward B; Kurata, Takayasu; Gray, Jhanelle E; Schwarzenberger, Paul; Jensen, Erin; Pietanza, M Catherine; Rodríguez-Abreu, Delvys
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Pembrolizumab Plus Chemotherapy in Squamous Non-Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study

帕博利珠单抗联合化疗治疗鳞状非小细胞肺癌：KEYNOTE-407 III期研究的5年更新

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.22.01990
Novello, Silvia; Kowalski, Dariusz M; Luft, Alexander; Gümüş, Mahmut; Vicente, David; Mazières, Julien; Rodríguez-Cid, Jeronimo; Tafreshi, Ali; Cheng, Ying; Lee, Ki Hyeong; Golf, Alexander; Sugawara, Shunichi; Robinson, Andrew G; Halmos, Balazs; Jensen, Erin; Schwarzenberger, Paul; Pietanza, M Catherine; Paz-Ares, Luis
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Society for Immunotherapy of Cancer (SITC) consensus definitions for immune checkpoint inhibitor-associated immune-related adverse events (irAEs) terminology

癌症免疫治疗学会 (SITC) 关于免疫检查点抑制剂相关免疫相关不良事件 (irAE) 术语的共识定义

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2022-006398
Naidoo, Jarushka; Murphy, Catherine; Atkins, Michael B; Brahmer, Julie R; Champiat, Stephane; Feltquate, David; Krug, Lee M; Moslehi, Javid; Pietanza, M Catherine; Riemer, Joanne; Robert, Caroline; Sharon, Elad; Suarez-Almazor, Maria E; Suresh, Karthik; Turner, Michelle; Weber, Jeffrey; Cappelli, Laura C
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2023
文献求助 收藏

Real-World Treatment Patterns and Outcomes of First-Line Immunotherapy Among Patients With Advanced Nonsquamous NSCLC Harboring BRAF, MET, or HER2 Alterations

BRAF、MET 或 HER2 突变晚期非鳞状非小细胞肺癌患者一线免疫治疗的真实世界治疗模式和结果

期刊:JTO Clinical and Research Reports
影响因子:3.5
doi:10.1016/j.jtocrr.2023.100568
Garassino, Marina C; Oskar, Sabine; Arunachalam, Ashwini; Zu, Ke; Kao, Yu-Han; Chen, Cai; Meng, Weilin; Pietanza, M Catherine; Zhao, Bin; Aggarwal, Himani
肺癌
肿瘤
HER2
肿瘤免疫
BRAF
细胞生物学
MET
免疫/内分泌
发表日期：2023
文献求助 收藏

Associations of Tissue Tumor Mutational Burden and Mutational Status With Clinical Outcomes With Pembrolizumab Plus Chemotherapy Versus Chemotherapy For Metastatic NSCLC

组织肿瘤突变负荷和突变状态与帕博利珠单抗联合化疗与单纯化疗治疗转移性非小细胞肺癌临床疗效的相关性

期刊:JTO Clinical and Research Reports
影响因子:3.5
doi:10.1016/j.jtocrr.2022.100431
Garassino, Marina C; Gadgeel, Shirish; Novello, Silvia; Halmos, Balazs; Felip, Enriqueta; Speranza, Giovanna; Hui, Rina; Garon, Edward B; Horinouchi, Hidehito; Sugawara, Shunichi; Rodriguez-Abreu, Delvys; Reck, Martin; Cristescu, Razvan; Aurora-Garg, Deepti; Loboda, Andrey; Lunceford, Jared; Kobie, Julie; Ayers, Mark; Piperdi, Bilal; Pietanza, M Catherine; Paz-Ares, Luis
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Patient-Reported Health-Related Quality of Life in KEYNOTE-604: Pembrolizumab or Placebo Added to Etoposide and Platinum as First-Line Therapy for Extensive-Stage SCLC

KEYNOTE-604研究中患者报告的健康相关生活质量：帕博利珠单抗或安慰剂联合依托泊苷和铂类药物作为广泛期小细胞肺癌一线治疗方案

期刊:JTO Clinical and Research Reports
影响因子:3.5
doi:10.1016/j.jtocrr.2023.100572
Kim, Hye Ryun; Awad, Mark M; Navarro, Alejandro; Gottfried, Maya; Peters, Solange; Csőszi, Tibor; Cheema, Parneet K; Rodriguez-Abreu, Delvys; Wollner, Mirjana; Yang, James Chih-Hsin; Mazieres, Julien; Orlandi, Francisco J; Luft, Alexander; Gümüş, Mahmut; Kato, Terufumi; Kalemkerian, Gregory P; Luo, Yiwen; Santorelli, Melissa L; Pietanza, M Catherine; Rudin, Charles M
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Molecular epidemiology study of programmed death ligand 1 and ligand 2 protein expression assessed by immunohistochemistry in extensive-stage small-cell lung cancer

通过免疫组织化学方法评估广泛期小细胞肺癌中程序性死亡配体1和配体2蛋白表达的分子流行病学研究

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2023.1225820
Steiniche, Torben; Georgsen, Jeanette Baehr; Meldgaard, Peter; Deitz, Anne C; Ayers, Mark; Pietanza, M Catherine; Zu, Ke
肺癌
肿瘤
IHC
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2023
文献求助 收藏